课题基金 / 基金详情

Dietary histone deactylase inhibitors in prostate cancer prevention

Dietary histone deactylase inhibitors in prostate cancer prevention
膳食组蛋白脱乙酰酶抑制剂预防前列腺癌
批准号:
7413331
负责人:
EMILY HO
金额:
$33.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2012-02-28
关键词:
AccountingAcetylationAddressAdverse effectsAmericanAnimal ModelAntineoplastic AgentsAntioxidantsApoptosisBiological AvailabilityBiological MarkersBroccoli - dietaryCDKN1A geneCancer EtiologyCancer PatientCell Cycle ArrestCellsCessation of lifeChemopreventionChemopreventive AgentChemoprotective AgentClinicalClinical TrialsColorectalConsumptionCutaneousDevelopmentDiagnosisDietDietary InterventionEnzymesEpidemiologic MethodsEpidemiologic StudiesEpidemiologistEpigenetic ProcessEquilibriumEventFoodFoundationsFutureGene ExpressionGene Expression RegulationGlobal ChangeGoalsHealthHealth Care CostsHealthcareHistone AcetylationHistone DeacetylaseHistone Deacetylase InhibitorHistone H3Histone deacetylase inhibitionHistonesHistopathologyHumanImmunohistochemistryIncidenceInhibition of ApoptosisInjection of therapeutic agentIntakeInterventionIntervention StudiesIntervention TrialInvestigationIsothiocyanatesLife StyleLinkMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMetabolismMethodsModelingModificationMolecularMorbidity - disease rateMusNormal CellNutritionalOutcomePathogenesisPathologistPathologyPathway interactionsPatientsPatternPharmaceutical PreparationsPhasePlayPopulationPopulation SciencesPopulations at RiskPrevention strategyPrevention therapyProcessProstateProstatic NeoplasmsPublic HealthQualifyingQuality of lifeRecommendationRecurrenceReportingRepressionResearchResearch PersonnelResponse ElementsRiskRoleSignal PathwaySignal TransductionSmall Interfering RNASulforaphaneTechniquesTestingTimeTissuesTrainingTumor SuppressionUnited StatesUp-RegulationWorkbasecancer cellcancer chemopreventioncancer preventioncancer riskcancer therapycarcinogenesiscostcruciferous vegetableexperiencegene repressionhigh risk menhistone acetyltransferaseimprovedinhibitor/antagonistinnovationinsightinterestliquid chromatography mass spectrometrymalemenmortalitymouse modelnovelnovel strategiesoncoprotein p21peripheral bloodprogramsprostate cancer preventionprotective effecttranslational studytumortumor growthtumor progressionurinary

项目摘要

项目成果

EMILY HO的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):前列腺癌是最常见的非皮肤癌症,是美国男性癌症死亡的第二大原因。启动和促进前列腺癌进展的确切病因尚不清楚,但表观遗传改变和饮食/生活方式因素已被认为是重要的因素。在前列腺癌期间,乙酰化模式的改变和组蛋白去乙酰化酶的增加是明显的。抑制hdac的药物在癌症预防和治疗中的应用已经引起了人们极大的兴趣。HDAC抑制剂引起乙酰化组蛋白的增加,选择性地诱导癌细胞的细胞周期阻滞和细胞凋亡,并在癌症临床试验中显示出希望。我们最近报道了一种在十字花科蔬菜中发现的化合物萝卜硫素(SFN)在动物模型中抑制肿瘤生长并抑制前列腺中HDAC的活性。基于这些发现,我们提出了以下中心假设:萝卜硫素作为前列腺中HDAC的抑制剂,导致组蛋白乙酰化和p21和Bax等基因的去抑制,有助于细胞周期阻滞和细胞凋亡,从而预防癌症。这些研究的长期目标是确定十字花科蔬菜降低前列腺癌风险的机制。这些研究的目的是确定新的前列腺化学保护剂,通过抑制HDAC和去抑制基因表达来预防癌症。具体而言,我们建议1)表征膳食中SFN对前列腺癌小鼠前列腺癌发生的影响。工作假设是SFN治疗会抑制TRAMP小鼠前列腺肿瘤的发展。抑制肿瘤发展将与抑制HDAC活性、乙酰化组蛋白水平的增加和细胞凋亡的增强有关。2)研究HDAC抑制对SFN诱导的细胞凋亡和化学预防的要求。目前的假设是,SFN抑制HDAC是导致SFN诱导p21和Bax表达和凋亡的关键机制。3)研究人类食用十字花科蔬菜对SFN代谢、HDAC活性和乙酰化组蛋白状态的影响。目前的假设是,大量摄入十字花科蔬菜会降低外周血中HDAC的活性,增加前列腺癌高危人群前列腺组织中乙酰化组蛋白的水平。
英文摘要
DESCRIPTION (provided by applicant): Prostate cancer is the most frequently diagnosed non-cutaneous cancer, and is the second leading cause of cancer death in American men. The precise etiologic factors that initiate and enhance the progression of prostate cancer remains unknown, but epigenetic alterations and diet/lifestyle factors have come forth as significant contributing factors. During prostate cancer, alterations in acetylation patterns and increases in histone deacetylases are apparent. The use of pharmacological agents that inhibit HDACs for cancer prevention and therapy have gained significant interest. HDAC inhibitors cause increases in acetylated histones, selectively induce cell cycle arrest and apoptosis in cancer cells and have shown promise in cancer clinical trials. We have recently reported that sulforaphane (SFN), a compound found in cruciferous vegetables, suppresses tumor growth in animal models and inhibits HDAC activity in prostate. Based on these findings we formulated the following central hypothesis: Sulforaphane acts as an inhibitor of HDAC in the prostate, resulting in the induction of histone acetylation and de-repression of genes such as p21 and Bax, contributing to cell cycle arrest and apoptosis, and thus cancer prevention. The long term goal of these studies is to determine the mechanisms by which cruciferous vegetables act to decrease prostate cancer risk. The objective of these studies is to identify novel prostate chemoprotective agents that act via HDAC inhibition and de-repression of gene expression leading to cancer prevention. Specifically, we propose to 1) Characterize the effects of dietary SFN on development of prostate cancer in a mouse for prostate carcinogenesis. The working hypothesis is that SFN treatment will suppress prostate tumor development in TRAMP mice. Suppression of tumor development will be associated with inhibition of HDAC activity, increases in the levels of acetylated histones and enhancement of apoptosis. 2) Examine the requirement of HDAC inhibition for SFN induced apoptosis and chemoprevention. The working hypothesis is that HDAC inhibition by SFN is a key mechanism leading to SFN-induced p21 and Bax expression and apoptosis.3) Examine in humans the effects dietary consumption of cruciferous vegetables on SFN metabolism, HDAC activity and acetylated histone status. The working hypothesis is that high cruciferous vegetable intake will be associated with lower HDAC activity in peripheral blood and increase acetylated histone levels in prostate tissue of men at high risk for prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated Health Sciences Facilities Core
  • 批准号:
    10383761
  • 项目类别:
  • 资助金额:
    $29.07万
  • 财政年份:
    2020
  • 负责人:
    EMILY HO
  • 依托单位:
Administrative Core
  • 批准号:
    10207637
  • 项目类别:
  • 资助金额:
    $31.83万
  • 财政年份:
    2020
  • 负责人:
    EMILY HO
  • 依托单位:
Pacific Northwest Center for Translational Environmental Health Research
  • 批准号:
    10383759
  • 项目类别:
  • 资助金额:
    $120.43万
  • 财政年份:
    2020
  • 负责人:
    EMILY HO
  • 依托单位:
Pacific Northwest Center for Translational Environmental Health Research
  • 批准号:
    10207636
  • 项目类别:
  • 资助金额:
    $120.43万
  • 财政年份:
    2020
  • 负责人:
    EMILY HO
  • 依托单位:
海外基金